1: Guo B, Su J, Zhang T, Wang K, Li X. Fangchinoline as a kinase inhibitor targets FAK and suppresses FAK-mediated signaling pathway in A549. J Drug Target. 2015 Apr;23(3):266-74. doi: 10.3109/1061186X.2014.992898. Epub 2014 Dec 24. doi: 10.1371/journal.pone.0141681. eCollection 2015. 3: Tian F, Ding D, Li D. Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells. Int J Oncol. 2015;46(6):2355-63. doi: 10.3892/ijo.2015.2959. Epub 2015 Apr 9. 4: Xing Z, Zhang Y, Zhang X, Yang Y, Ma Y, Pang D. Fangchinoline induces G1 arrest in breast cancer cells through cell-cycle regulation. Phytother Res. 2013 Dec;27(12):1790-4. doi: 10.1002/ptr.4936. Epub 2013 Feb 11. doi: 10.1093/chromsci/bmv016. Epub 2015 Mar 8. doi: 10.1016/j.phymed.2014.04.029. Epub 2014 May 22. doi: 10.1002/jssc.201401384. Epub 2015 Mar 10. doi: 10.1007/s13277-015-3990-1. Epub 2015 Sep 25. doi: 10.1371/journal.pone.0039225. Epub 2012 Jun 13.
合成参考文献
参考文献:10.1055/s-1999-14017 摘要:Steele JC, Simmonds MS, Veitch NC, Warhurst DC. Evaluation of the anti-plasmodial activity of bisbenzylisoquinoline alkaloids from Abuta grandifolia. Planta Med. 1999 Jun;65(5):413–6. doi: 10.1055/s-1999-14017.